Evidence map›Paper›PMID 30847584›Full record

ArticlePharmaceutical research2019

Biomimetic Hydroxyapatite a Potential Universal Nanocarrier for Cellular Internalization & Drug Delivery.

Ashu Srivastav, Balasaheb Chandanshive, Prajakta Dandekar, Deepa Khushalani, Ratnesh Jain

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ashu SrivastavDepartment of Chemical Engineering, Institute of Chemical Technology, Matunga (E), Mumbai, 400019, India.
Balasaheb ChandanshiveDepartment of Chemical Sciences, Tata Institute of Fundamental Research, Colaba, Mumbai, 400005, India.
Prajakta DandekarDepartment of Pharmaceutical Science & Technology, Institute of Chemical Technology, Matunga (E), Mumbai, 400019, India.
Deepa KhushalaniDepartment of Chemical Sciences, Tata Institute of Fundamental Research, Colaba, Mumbai, 400005, India. khushalani@tifr.res.in.ORCID http://orcid.org/0000-0002-6838-1394
Ratnesh JainDepartment of Chemical Engineering, Institute of Chemical Technology, Matunga (E), Mumbai, 400019, India. rd.jain@ictmumbai.edu.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeFunctional biomaterials can be used as drug loading devices, components for tissue engineering or as biological probes. As such, the design, synthesis and evaluation of a variety of local-drug delivery structures has been undertaken over the past few decades with the ultimate aim of providing materials that can encapsulate a diverse array of drugs (in terms of their sizes, chemical compositions and chemical natures (i.e. hydrophilic/hydrophobic).

methodsPresented here is the evaluation of specifically hollow 1D structures consisting of nanotubes (NTs) of HAp and their efficacy for cellular internalization using two distinguished anti-cancer model drugs: Paclitaxel (hydrophobic) and Doxorubicin hydrochloride (hydrophilic).

resultsImportantly, it has been observed through this work that HAp NTs consistently showed not only higher drug loading capacity as compared to HAp nanospheres (NSs) but also had better efficacy with respect to cell internalization/encapsulation. The highly porous structure, with large surface area of nanotube morphology, gave the advantage of targeted delivery due to its high drug loading and retention capacity. This was done using the very simple techniques of physical adsorption to load the drug/dye molecules and therefore this can be universally applied to a diverse array of molecules.

conclusionsOur synthesized nanocarrier can be widely employed in biomedical applications due to its bio-compatible, bio-active and biodegradable properties and as such can be considered to be a universal carrier. Graphical Abstract Schematic representation for a comparative study of hydroxyapatite (hollow nanotubes vs solid nanospheres) with variety of drug/ dye molecules.

Indexed as

AdsorptionAntineoplastic AgentsBiocompatible MaterialsBiomimeticsCell Line, TumorCells, CulturedDoxorubicinDrug CarriersDrug Delivery SystemsDurapatiteHeLa CellsHumansHydrophobic and Hydrophilic InteractionsNanospheresNanotubesPorosityAntineoplastic AgentsBiocompatible MaterialsDoxorubicinDrug CarriersDurapatiteconfocal microscopycytotoxicitydrug deliverymorphology

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.